News

We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...
Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.
Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners ...
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...
Defense and security solutions provider KRATOS DEFENSE AND SECURITY SOLUTIONS INC (NASDAQ: KTOS) saw a sell-off by ARK, with 36,628 shares sold between the ARKQ and ARKX (NYSE: ARKX) ETFs, valued at ...
View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return ...
Young women diagnosed with breast cancer have a relatively low risk of isolated locoregional recurrence (LRR) after initial treatment, according to a large retrospective study.